(1) Hazard communication - General.
(a) Chemical manufacturers, importers, distributors and employers must comply with all requirements of the Hazard Communication Standard (HCS), WAC
296-901-140 for MDA.
(b) In classifying the hazards for MDA at least the following hazards are to be addressed: Cancer; liver effects; and skin sensitization.
(c) You must include MDA in the hazard communication program established to comply with the HCS, WAC
296-901-140. You must ensure that each employee has access to labels on containers of MDA and to safety data sheets, and is trained in accordance with the requirements of HCS and subsection (4) of this section.
(2) Signs and labels.
(a) Signs.
(i) You must post and maintain legible signs demarcating regulated areas and entrances or accessways to regulated areas that bear the following legend:
DANGER MDA MAY CAUSE CANCER CAUSES DAMAGE TO THE LIVER
RESPIRATORY PROTECTION AND PROTECTIVE CLOTHING
MAY BE REQUIRED IN THIS AREA
AUTHORIZED PERSONNEL ONLY
(ii) Prior to June 1, 2016, you may use the following legend in lieu of that specified in (a)(i) of this subsection:
DANGER MDA MAY CAUSE CANCER LIVER TOXIN
AUTHORIZED PERSONNEL ONLY
RESPIRATORS AND PROTECTIVE CLOTHING MAY BE REQUIRED TO BE WORN IN THIS AREA
(b) Labels. Prior to June 1, 2015, you may include the following information workplace labels in lieu of the labeling requirements in subsection (1) of this section:
(i) For pure MDA:
DANGER CONTAINS MDA MAY CAUSE CANCER LIVER TOXIN
(ii) For mixtures containing MDA:
DANGER CONTAINS MDA CONTAINS MATERIALS
WHICH MAY CAUSE CANCER LIVER TOXIN
(3) Safety data sheets (SDS).
In meeting the obligation to provide safety data sheets, you must make appropriate use of the information found in Appendices A and B to WAC
296-62-076.
(4) Information and training.
(a) You must provide employees with information and training on MDA, in accordance with WAC
296-901-14016, at the time of initial assignment and at least annually thereafter.
(b) In addition to the information required under WAC
296-901-140, you must:
(i) Provide an explanation of the contents of this section, including Appendices A and B of this section, and indicate to employees where a copy of the standard is available;
(ii) Describe the medical surveillance program required under WAC
296-155-17327, and explain the information contained in Appendix C of this standard; and
(iii) Describe the medical removal provision required under WAC
296-155-17327.
(5) Access to training materials.
(a) You must make readily available to all affected employees, without cost, all written materials relating to the employee training program, including a copy of this regulation.
(b) You must provide to the director, upon request, all information and training materials relating to the employee information and training program.
[Statutory Authority: RCW
49.17.010,
49.17.040,
49.17.050,
49.17.060. WSR 16-09-085, § 296-155-17323, filed 4/19/16, effective 5/20/16. Statutory Authority: RCW
49.17.010,
49.17.040,
49.17.050,
49.17.060 and 29 C.F.R. 1910 Subpart Z. WSR 14-07-086, § 296-155-17323, filed 3/18/14, effective 5/1/14. Statutory Authority: RCW
49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-155-17323, filed 5/9/01, effective 9/1/01. Statutory Authority: Chapter
49.17 RCW. WSR 93-04-111 (Order 92-15), § 296-155-17323, filed 2/3/93, effective 3/15/93.]
